Mythic Therapeutics

0 followers


Mythic Therapeutics’ innovative FateControl technology expands the potential of Antibody Drug Conjugates (ADCs) to destroy cancer and avoid normal cells.

Employees

11-50

Links

Org chart

Sandra Poole
Chief Operating Officer
Nick Mathisen
VP, Head of Information Technology